Pseudomembranous colitis by Clostridium difficile infection: a case report in pediatric patient
Abstract
Clostridium difficile is a bacillus Gram positive and spore form, anaerobic strictly, resistant to adverse conditions and transmitted by oral - fecal route, it was described by the first time in 1930, nevertheless it’s has been associated to disease in human beings in the decade of the seventies it identified as causal agent of pseudomembranous colitis. Its infection has related to diverse clinical manifestations such as diarrhea without complications, which lead to sepsis and inclusive the death. In the following clinical case we have a male infant 1 year old and 18 months patient, with precedents of hyperthermia and liquid depositions, after several days of antibiotics treatment, the symptoms increased with elimination of membranous rest in the faeces; reason why he is transferred to a hospital, in which the Clostridium difficile toxins test is realized, yielding positive results, therefore the diagnosis of pseudomembranous colitis is established metronidazole and vancomycin is given for 7 days having a favorable development. The use of antibiotics is a predisposing factor of pseudomembranous colitis for the affectation of the intestinal microbiota, in addition hospital stays and intrinsic factors. The literature describes a limited number of studies about this infection in pediatric patients, hence the importance of the case report
References
Orellana A, Salazar E.. Colitis Pseudomembranosa asociada al uso de antibióticos.ActaOdont,2009;47(2).Disponibleen:https://www.actaodontologica.com/ediciones/2009/2/art-25/ (acceso 25.06.17)
Meyer-S L, Espinoza-A R, Quera-P R. Infección por Clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticas. Rev. Med. Clin.CONDES, 2014; 25(3): 473-484.
Voth DE, Ballard JD. Action and role in disease Clostridium difficile toxins: Mechanism of action and role in disease. ClinMicrobiol. Rev, 2005; 18 (2):247-63.
Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ, 2004; 171(1): 51-58.
Tenover FC, Baron EJ, Peterson LR, Persing DH. Laboratory diagnosis of
Clostridium difficile infection. Can molecular amplification methods move usout of uncertainty? J MolDiagn, 2011; 13: 573-582.
Pérez C. Probióticos en la diarrea aguda y asociada al uso de antibióticos en Pediatría. NutriciónHospitalaria,2015; 31(Supl. 1):64-67.
Alonso-Sanz MGAMJ. New methodological advances: Algorithm proposal for management of Clostridium difficile infection. Revista Española de Quimioterapia, 2015; 28(3):157-159.
Asensio A, Mongue D. Epidemiología de la infección por Clostridium difficile en España. Revisión. Enferm Infecc Microbiol Clin, 2012; 30:333-7.
Blanco-Pérez A, Ruiz O, Otero W, Gómez M. Infección por Clostridium difficile en ancianos. Artículo de Revisión. Rev Col Gastroenterol, 2013; 28 (1): 53-63.
Debast SB, Bauer MP, Kuiiper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clinical microbiology and infection.Clin Microbiol Infect, 2014; Suppl 2:1-26. doi: 10.1111/1469-0691.12418
Copyright (c) 2017 Johanna Villamarín, Ruth Mejía, Patricia Paredes, Sandra Villacís, Yenddy Carrero
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.
The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.
Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.
_pequeño1.png)
_pequeña.png)
_pequeña.png)
_pequeña.jpg)
